{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T05:22:43Z","timestamp":1746422563096},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.clim.2014.05.001","type":"journal-article","created":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T22:30:29Z","timestamp":1400365829000},"page":"288-291","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A novel disease-causing CD40L mutation reduces expression of CD40 ligand, but preserves CD40 binding capacity"],"prefix":"10.1016","volume":"153","author":[{"given":"Nur\u015fen C.","family":"G\u00fcnaydin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neslihan E.","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fczide","family":"Aksu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel J.","family":"Massaad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Azarsiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yesim","family":"Ertan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raif S.","family":"Geha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necil","family":"K\u00fct\u00fck\u00e7\u00fcler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2014.05.001_bb0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2141.2010.08077.x","article-title":"Update on the hyper immunoglobulin M syndromes","volume":"149","author":"Davies","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clim.2014.05.001_bb0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.clim.2014.05.001_bb0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1399-0004.2012.01953.x","article-title":"Clinical and genetic analysis of patients with X-linked hyper-IgM syndrome","volume":"83","author":"Vargas-Hernandez","year":"2013","journal-title":"Clin. Genet."},{"key":"10.1016\/j.clim.2014.05.001_bb0020","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V92.7.2421","article-title":"Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome","volume":"92","author":"Seyama","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clim.2014.05.001_bb0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.anai.2013.02.011","article-title":"Hyper immunoglobulin M syndrome in a 15-year-old boy caused by a Gly219Arg missense mutation","volume":"110","author":"Katta","year":"2013","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.clim.2014.05.001_bb0030","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/jcp.2008.058362","article-title":"Cerebral toxoplasmosis in a middle-aged man as first presentation of primary immunodeficiency due to a hypomorphic mutation in the CD40 ligand gene","volume":"61","author":"Yong","year":"2008","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.clim.2014.05.001_bb0035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/361541a0","article-title":"CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM","volume":"361","author":"DiSanto","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.clim.2014.05.001_bb0040","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-4632.2009.03809.x","article-title":"Relapsing polychondritis in a child with common variable immunodeficiency","volume":"48","author":"Karaca","year":"2009","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.clim.2014.05.001_bb0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2277-9175.124627","article-title":"Genetic defects and the role of helper T-cells in the pathogenesis of common variable immunodeficiency","volume":"3","author":"Yazdani","year":"2014","journal-title":"Adv. Biomed. Res."},{"issue":"10","key":"10.1016\/j.clim.2014.05.001_bb0050","first-page":"11.10.11","article-title":"From FastQ data to high-confidence variant calls: the Genome Analysis Toolkit best practices pipeline","volume":"11","author":"Van der Auwera","year":"2013","journal-title":"Curr. Protoc. Bioinforma."},{"key":"10.1016\/j.clim.2014.05.001_bb0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","article-title":"Clinical spectrum of X-linked hyper-IgM syndrome","volume":"131","author":"Levy","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2014.05.001_bb0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s15010-010-0061-9","article-title":"Pitfalls of \u201chyper\u201d-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature","volume":"38","author":"Heinold","year":"2010","journal-title":"Infection"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661614001284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661614001284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T15:33:35Z","timestamp":1597851215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661614001284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1521661614001284"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2014.05.001","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel disease-causing CD40L mutation reduces expression of CD40 ligand, but preserves CD40 binding capacity","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2014.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}